| 5YB1: reference: Developing an Anticancer Copper(II) Multitarget Pro-Drug Based on the His146 Residue in the IB Subdomain of Modified Human Serum Albumin., Wang J, Gou Y, Zhang Z, Yu P, Qi J, Qin Q, Sun H, Wu X, Liang H, Yang F, Mol Pharm. 2018 Jun 4;15(6):2180-2193. doi: 10.1021/acs.molpharmaceut.8b00045., Epub 2018 May 10. PMID: 29722993 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).